Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CHAO, Richard C")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 8 of 8

  • Page / 1
Export

Selection :

  • and

Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapySALTZ, Leonard B; ROSEN, Lee S; XIN HUANG et al.Journal of clinical oncology. 2007, Vol 25, Num 30, pp 4793-4799, issn 0732-183X, 7 p.Article

Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies—results of a phase I dose-escalation studyBLAIS, Normand; CAMIDGE, D. Ross; CHOW, Laura Q et al.Investigational new drugs. 2013, Vol 31, Num 6, pp 1487-1498, issn 0167-6997, 12 p.Article

Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non―Small-Cell Lung Cancer: A Phase III TrialSCAGLIOTTI, Giorgio V; KRZAKOWSKI, Maciej; PAPAI, Zsolt S et al.Journal of clinical oncology. 2012, Vol 30, Num 17, pp 2070-2078, issn 0732-183X, 9 p.Article

Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancerGERVAIS, Radj; HAINSWORTH, John D; SELARU, Paulina et al.Lung cancer. 2011, Vol 74, Num 3, pp 474-480, issn 0169-5002, 7 p.Article

Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study resultsHEATH, Elisabeth I; BLUMENSCHEIN, George R; COHEN, Roger B et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 3, pp 703-712, issn 0344-5704, 10 p.Article

Multicenter, Phase II Trial of Sunitinib in Previously Treated, Advanced Non-Small-Cell Lung CancerSOCINSKI, Mark A; NOVELLA, Silvia; TYE, Lesley et al.Journal of clinical oncology. 2008, Vol 26, Num 4, pp 650-656, issn 0732-183X, 7 p.Article

Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumorITO, Tetsuhide; OKUSAKA, Takuji; HASHIGAKI, Satoshi et al.Investigational new drugs. 2013, Vol 31, Num 5, pp 1265-1274, issn 0167-6997, 10 p.Article

Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesotheliomaCAMIDGE, D. Ross; BLAIS, Normand; CHOW, Laura Q et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 2, pp 307-319, issn 0344-5704, 13 p.Article

  • Page / 1